Rajeev Vibhakar
Impact in
- Genetics top 1%
- Glioma Diagnosis and Treatment
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Genetics 38
- Glioma Diagnosis and Treatment 37
- Co-authors
- Nicholas K. ForemanSujatha VenkataramanAndrew M. DonsonDiane K. BirksIrina AlimovaPeter S. HarrisMichael H. HandlerRong Fan
- Journals
- Neuro-Oncology (22 papers)Journal of Neuro-Oncology (6 papers)Pediatric Blood & Cancer (6 papers)Cancer Research (5 papers)Oncotarget (4 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Rajeev Vibhakar
89 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 93
- Genetics 628
- Cancer Research 760
- Molecular Biology 2.1k
- Oncology 660
- Immunology 421
Countries citing papers authored by Rajeev Vibhakar
This map shows the geographic impact of Rajeev Vibhakar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rajeev Vibhakar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rajeev Vibhakar more than expected).
Fields of papers citing papers by Rajeev Vibhakar
This network shows the impact of papers produced by Rajeev Vibhakar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rajeev Vibhakar. The network helps show where Rajeev Vibhakar may publish in the future.
Co-authors
The 25 scholars most cited alongside Rajeev Vibhakar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 1 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 4 | |
| 9 | 2023 | 4 | |
| 10 | 2023 | 0 | |
| 11 | 2023 | 0 | |
| 12 | 2022 | 12 | |
| 13 | 2020 | 26 | |
| 14 | 2020 | 43 | |
| 15 | 2019 | 18 | |
| 16 | 2018 | 23 | |
| 17 | 2017 | 55 | |
| 18 | 2015 | 56 | |
| 19 | 2012 | 102 | |
| 20 | 2006 | 122 |
About Rajeev Vibhakar
Rajeev Vibhakar is a scholar working on Genetics, Cancer Research, Molecular Biology, Pathology and Forensic Medicine and Structural Biology, having authored 98 papers that have together received 2.9k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (37 papers), Chromatin Remodeling and Cancer (19 papers), Protein Degradation and Inhibitors (16 papers), Cancer Mechanisms and Therapy (13 papers), Genomics and Chromatin Dynamics (10 papers), Microtubule and mitosis dynamics (9 papers), Histone Deacetylase Inhibitors Research (9 papers) and Epigenetics and DNA Methylation (9 papers). The work is most often cited by research in Genetics (628 citations), Cancer Research (760 citations), Molecular Biology (2.1k citations), Oncology (660 citations) and Immunology (421 citations). Rajeev Vibhakar has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Nicholas K. Foreman, Sujatha Venkataraman, Andrew M. Donson, Diane K. Birks, Irina Alimova, Peter S. Harris, Michael H. Handler, Rong Fan, Bruce S. Hostager and Michael D. Taylor. Their work appears in journals such as Neuro-Oncology, Journal of Neuro-Oncology, Pediatric Blood & Cancer, Cancer Research and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.